The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of hypofractionated radiotherapy and pembrolizumab in the treatment of muscle invasive/metastatic bladder cancer: Results of the PLUMMB trial.
 
Robert Huddart
Leadership - Cancer clinic london Limited liability partnership
Consulting or Advisory Role - Bayer; BioNTech SE; Gilead Sciences; Janssen; Janssen Oncology; Merck; Merck Sharp & Dohme; Nektar; Roche
Speakers' Bureau - Bristol Myers Squibb Foundation; Pfizer
Research Funding - Astellas Pharma (Inst); Basilea (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for dug discovery from Janssen (Inst)
Travel, Accommodations, Expenses - Janssen; Nektar; Roche/Genentech
 
Shaista Hafeez
Research Funding - Elekta (Inst)
 
Emilia Nuzzaci
No Relationships to Disclose
 
Kelly Jones
No Relationships to Disclose
 
Alison Tree
Employment - UK NHS
Leadership - Elekta MRL Consortium (Inst)
Honoraria - Accuray; Bayer; Elekta; Janssen (Inst)
Research Funding - Accuray (Inst); Elekta (Inst)
Travel, Accommodations, Expenses - Elekta MRL Consortium
Other Relationship - IJROBP journal
 
Emily Greenlay
No Relationships to Disclose